Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome.
Yushi UekiShusuke OhshimaJo OmataYusuke YokoyamaTakeshi TakahashiRyusuke ShodoKeisuke YamazakiArata HoriiPublished in: Cancer medicine (2023)
Monitoring AEC during nivolumab therapy may be useful in predicting irAE occurrence, nivolumab discontinuation, and disease prognosis.